4//SEC Filing
Drygin Denis 4
Accession 0001209191-20-044925
CIK 0001505512other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:12 AM ET
Size
5.5 KB
Accession
0001209191-20-044925
Insider Transaction Report
Form 4
Drygin Denis
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-03+300,000→ 300,000 totalExercise: $0.69Exp: 2030-08-02→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001819692
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 9:12 AM ET
- Size
- 5.5 KB